FdaApplication
ANDA 209821
Identifiers
- fda_app_no: ANDA209821
Properties
| Property | Value |
|---|---|
| applicant_name | EDENBRIDGE PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2020-08-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| YARGESA | MIGLUSTAT | 100MG | CAPSULE;ORAL |
1 product